Ajanta Pharma Limited AJANTPHARM

Latest filings

• Pledge76 28 Sept, 09:23 · BSE
  The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on September 28, 2026 for Aayush Agrawal, ....
• Routine15 25 Sept, 09:48 · NSE
  Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
• Pledge76 18 Sept, 16:31 · BSE
  The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on September 18, 2026 for Aayush Agrawal, ....
• Routine15 31 Aug, 11:46 · NSE
  Analysts/Institutional Investor Meet/Con. Call Updates
• Routine15 31 Aug, 11:44 · BSE
  Ajanta Pharma Ltd - 532331 - Participation In Investor Conference
• Routine15 31 Aug, 10:13 · BSE
  Ajanta Pharma Ltd - 532331 - Announcement under Regulation 30 (LODR)-Newspaper Publication
• Pledge79 27 Aug, 15:31 · BSE
  Ajanta Pharma Ltd - 532331 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
• Pledge79 19 Aug, 17:41 · BSE
  Ajanta Pharma Ltd - 532331 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
• Pledge79 14 Aug, 12:50 · BSE
  Ajanta Pharma Ltd - 532331 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
• Routine15 5 Aug, 16:55 · BSE
  Ajanta Pharma Ltd - 532331 - Participation In Investor Conference

Shown 15 minutes after publication. Real time with Pro.